Business
Target says it’s on track to end its sales slump after another lackluster quarter
MINNEAPOLIS — Target on Tuesday posted another quarter of falling revenue and customer traffic at its stores, though its shares rose as the retailer’s earnings beat estimates and it said it is poised to end its sales slump.
The big-box retailer, which is in the middle of a turnaround effort, said sales and traffic trends picked up in the last two months of the holiday quarter. Then sales turned positive year over year in February, which is the beginning of the current quarter.
Speaking to CNBC on Tuesday, Target CEO Michael Fiddelke said the company is “out of the gates strong this year.” While he noted that one month of growth “does not make a trend,” he said the February sales increase gives him “confidence” the company is moving back to growth.
For the current fiscal year, Target expects net sales to rise about 2% compared with the prior year and anticipates that metric will grow in every quarter of the year. That net sales growth for the year would reflect a small increase in comparable sales, the retailer said. The company added that its new stores and nonmerchandise sales, such as advertising and membership, would contribute more than 1 percentage point of growth.
Sign at the entrance to a Target store in Venice, Florida.
Erik Mcgregor | Lightrocket | Getty Images
Target said it expects full-year adjusted earnings per share to range from $7.50 to $8.50. Its adjusted earnings per share for the most recent full year were $7.57.
Fiddelke, who stepped into the company’s top role on Feb. 1, will try to persuade Wall Street that the retailer is gaining sales momentum at an investor meeting on Tuesday morning at Target’s Minneapolis headquarters.
Here’s what the company reported for the fiscal fourth quarter compared with Wall Street’s estimates, according to a survey of analysts by LSEG:
- Earnings per share: $2.44 adjusted vs. $2.16 expected
- Revenue: $30.45 billion vs. $30.48 billion expected
Target shares closed more than 6% higher on Tuesday.
The big-box retailer missed Wall Street’s revenue expectations for the fourth quarter, despite analysts already anticipating weaker sales. Its quarterly revenue dropped about 1.5% from $30.92 billion in the year-ago period.
For four quarters in a row, customer traffic across the company’s stores and website has fallen.
Target’s net income for the three-month period that ended Jan. 31 fell to $1.05 billion, or $2.30 per share, compared with $1.10 billion, or $2.41 per share, a year earlier. Excluding one-time items, including legal settlement gains and business transformation costs, Target’s adjusted earnings per share were $2.44.
Target is trying to end several years of disappointing results driven by a mix of company missteps and economic factors. Its annual sales have been roughly flat for four years, after a significant jump in annual revenue during the Covid pandemic.
Shares of the company have dropped by nearly 32% over the past three years, as of Monday’s close, though they have risen nearly 16% so far this year.
As it tries to turn its business around, Target cut 1,800 corporate jobs in October, marking its first major layoff in a decade.
Some of Target’s customers told CNBC they are shopping elsewhere after noticing changes like sloppier stores and lackluster merchandise, or objecting to the company’s social stances, like its rollback of major diversity, equity, inclusion initiatives. The company acknowledged backlash to its DEI decision had hurt sales and led to market share losses to competitors.
Target’s challenge with attracting shoppers has persisted. Comparable sales, an industry metric that takes out short-term factors like store openings and closures and is also called same-store sales, decreased 2.5% year over year in the fourth quarter. That reflected a 3.9% comparable sales decline at Target’s stores and a 1.9% increase across Target’s website and app.
Transactions across Target’s stores and website fell by 2.9% year over year. The average amount that customers spent during those transactions grew 0.4% year over year.
In an interview with CNBC in the fall at Target’s headquarters, Fiddelke said he would prioritize regaining the company’s reputation for style and design, improving the customer experience, and using technology to boost its performance.
He echoed those key goals on Tuesday, telling CNBC the company wants to prioritize “incredible product and [an] incredible experience.”
Last month, Target also announced it would invest more in store labor and cut about 500 roles at distribution centers and regional offices to try to address shoppers’ concerns about out-of-stocks, long checkout lines and other store conditions. However, the company declined to say much more it would spend.
“We know we have to equip our teams to have the resources they need to deliver an incredible store experience,” he told CNBC on Tuesday.
At an investor presentation Tuesday, Chief Financial Officer Jim Lee said that Target will step up its spending this year to support the company’s turnaround. He said capital expenditures will total about $5 billion this fiscal year, an increase of more than $1 billion from last fiscal year.
That spending will go toward Target’s supply chain, technology and investment in stores. It plans to open more than 30 new stores and remodel more than 130 stores this fiscal year.
Target is known for selling clothing, home goods, seasonal items and other trend-driven discretionary merchandise that customers often buy on impulse when browsing the aisles on a “Target run.” Yet higher prices of food, utilities and other necessities, fueled by inflation and tariffs, has dampened U.S. consumers’ willingness to buy items that aren’t on the shopping list.
Fiddelke told CNBC he does not see anything “remarkably different” about shopper behavior now relative to recent quarters.
He also did not say how he expects President Donald Trump’s new 10% global tariff to affect the company after the Supreme Court struck down broader duties last month. He told CNBC “we’ll find out together what the next year holds on the tariff front.” Fiddelke also did not say whether Target would take legal action to get tariff refunds, as companies like FedEx and Costco did.
Target’s results in recent years have been at odds with those of retail rivals like Walmart, Costco and T.J. Maxx’s parent, TJX, which have posted stronger sales results, attracted shoppers across incomes, and seen growth in categories like apparel and home goods, areas where Target has struggled.
Along with offering products like groceries, clothing, and home goods, Target is trying to sell more advertisements and membership subscriptions to customers. The company’s nonmerchandise sales jumped more than 25% in the fourth quarter, driven by membership revenue more than doubling from a year ago, double-digit percentage gains in its ads business, Roundel, and over 30% growth in its third-party marketplace.
Same-day deliveries through Target Circle 360 grew more than 30% year over year. The subscription service costs $99 per year or $10.99 on a monthly basis.
Business
Anthropic officially designated a supply chain risk by Pentagon
The supply chain risk designation of the artificial intelligence firm is a first for a US company.
Source link
Business
FDA official calls UniQure’s gene therapy a ‘failed’ treatment for Huntington’s disease
Thomas Fuller | SOPA Images | Lightrocket | Getty Images
UniQure needs to run another study to prove that its gene therapy “actually helps people with Huntington’s disease,” a senior U.S. Food and Drug Administration official said on a call with reporters Thursday.
The official, who requested anonymity before discussing sensitive information, confirmed the agency has asked the company to run a placebo controlled trial of its treatment, which is administered directly into the brain. UniQure has said that type of study isn’t ethical because it would require putting people under general anesthesia for hours, a characterization the official disputed.
“So what is really going on? UniQure is the latest company to make a failed therapy for Huntington’s patients,” the official said. “They likely acknowledge or understand at some deep level that their trial failed years ago, and instead of doing the right thing and running the correct clinical study, UniQure is performing a distorted or manipulated comparison in the mind of FDA.”
The comments mark the latest development in a messy public spat between UniQure and the FDA, and as the agency comes under fire for a number of recent drug approval application rejections, including some where companies have accused it of going back on previous guidance. FDA Commissioner Marty Makary in an interview with CNBC’s Becky Quick last week seemingly criticized UniQure’s gene therapy for Huntington’s disease. Makary didn’t name UniQure but described its treatment.
UniQure then accused the FDA of reversing its stance that the company’s clinical trial data would be sufficient to seek approval. UniQure’s study used an outside database to measure how patients with Huntington’s disease might decline without treatment, known as an external control. UniQure has said it wouldn’t be feasible to run a true randomized, double-blind placebo-controlled study, considered the gold standard, because it wouldn’t be ethical to make people undergo a sham hours-long brain surgery.
The FDA official said the agency “never agreed to accept this distorted comparison” and the FDA “never makes such assurances.” Instead, the “FDA will always say, ‘Well, we have to see the data when we get it.'”
UniQure didn’t immediately comment.
The company’s stock rose more than 10% on Thursday and has fallen 58% this year as of Thursday afternoon.
Business
US mortgage rates rise to 6% after three-week slide as oil-driven bond yields climb – The Times of India
The average long-term US mortgage rate edged higher this week, ending a three-week decline as bond yields rose amid oil-price pressures linked to the war with Iran.The benchmark 30-year fixed mortgage rate increased to 6% from 5.98% last week, mortgage buyer Freddie Mac said on Thursday. A year ago, the average rate stood at 6.63%, AP reported.The modest uptick breaks a three-week slide in borrowing costs, with mortgage rates having hovered close to the 6% mark for most of this year. Last week’s average had marked the first time the rate dipped below 6% since September 2022, reaching its lowest level in nearly three and a half years.Mortgage rates are influenced by several factors, including the Federal Reserve’s interest-rate policy, investor expectations about inflation and economic growth, and movements in the bond market.They typically track the direction of the 10-year US Treasury yield, which lenders use as a benchmark for pricing home loans.The 10-year Treasury yield rose to 4.14% at midday Thursday, up from around 4% a week earlier.Treasury yields have moved higher in recent days as rising oil prices added fresh inflation concerns, potentially complicating the Federal Reserve’s plans to cut interest rates.
-
Business7 days agoIndia Us Trade Deal: Fresh look at India-US trade deal? May be ‘rebalanced’ if circumstances change, says Piyush Goyal – The Times of India
-
Business1 week agoAttock Cement’s acquisition approved | The Express Tribune
-
Politics1 week agoWhat are Iran’s ballistic missile capabilities?
-
Politics1 week agoUS arrests ex-Air Force pilot for ‘training’ Chinese military
-
Fashion1 week agoPolicy easing drives Argentina’s garment import surge in 2025
-
Business6 days agoGreggs to reveal trading amid pressure from cost of living and weight loss drugs
-
Sports1 week agoSri Lanka’s Shanaka says constant criticism has affected players’ mental health
-
Sports6 days agoLPGA legend shares her feelings about US women’s Olympic wins: ‘Gets me really emotional’
